Evidence map›Paper›PMID 10417351›Full record

ArticleThe Biochemical journal1999

Phosphorylation and activation of phosphodiesterase type 3B (PDE3B) in adipocytes in response to serine/threonine phosphatase inhibitors: deactivation of PDE3B in vitro by protein phosphatase type 2A.

S Resjö, A Oknianska, S Zolnierowicz, V Manganiello, E Degerman

Open access · greenAbstract read
In one paragraph

Article in The Biochemical journal, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Reduced density and altered regulation of rat atrial L-type CaAmerican journal of physiology. Heart and circulatory physiology · 2017
    Article
  9. Article
  10. Article
  11. Article
  12. Regulation of p27American journal of cancer research · 2016
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

S ResjöSection for Molecular Signalling, Department of Cell and Molecular Biology, Lund University, P.O. Box 94, S-221 00 Lund, Sweden.
A Oknianska
S Zolnierowicz
V Manganiello
E Degerman
Lund University · SEUniversity of Gdańsk · PL

Funding

Expression, Structure/function, Regulation, and Roles of PDE3 IsoformsZIAHL002540 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI MANGANIELLO, VINCENT · 2009 to 2016
$17.0M
Phosphodiesterase 3 IsoformsZ01HL002540 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI MANGANIELLO, VINCENT · 1995 to 2008
$4.4M
STRUCTURE /FUNCTION OF PHOSPHODIESTERASE 3 ISOFORMSZ01HL000654 · NHLBI · HEART, LUNG, AND BLOOD INSTITUTE · PI MANGANIELLO, VINCENT · 1991 to 2000
–
6 · The paper itself

Abstract

Phosphodiesterase type 3B (PDE3B) has been shown to be activated and phosphorylated in response to insulin and hormones that increase cAMP. In order to study serine/threonine protein phosphatases involved in the regulation of rat adipocyte PDE3B, we investigated the phosphorylation and activation of PDE3B in vivo in response to phosphatase inhibitors and the dephosphorylation and deactivation of PDE3B in vitro by phosphatases purified from rat adipocyte homogenates. Okadaic acid and calyculin A induced dose- and time-dependent activation of PDE3B. Maximal effects were obtained after 30 min using 1 microM okadaic acid (1.8-fold activation) and 300 nM calyculin A (4-fold activation), respectively. Tautomycin and cyclosporin A did not induce activation of PDE3B. Incubation of adipocytes with 300 nM calyculin A inhibited protein phosphatase (PP) 1 and PP2A completely. Okadaic acid (1 microM) reduced PP2A activity by approx. 50% but did not affect PP1 activity, and 1 microM tautomycin reduced PP1 activity by approx. 60% but PP2A activity by only 11%. This indicates an important role for PP2A in the regulation of PDE3B. Furthermore, rat adipocyte PDE3B phosphatase activity co-purified with PP2A but not with PP1 during MonoQ chromatography. As compared with insulin, okadaic acid and calyculin A induced phosphorylation of PDE3B by 2.8- and 14-fold respectively, whereas tautomycin and cyclosporin A had no effect. Both calyculin A and okadaic acid induced phosphorylation on serine 302, the site known to be phosphorylated on PDE3B in response to insulin and isoproterenol (isoprenaline), as well as on sites not identified previously. In summary, PP2A seems to be involved in the regulation of PDE3B in vivo and can act as a PDE3B phosphatase in vitro. In comparison with insulin, calyculin A induced a dramatic activation of PDE3B and both calyculin A and okadaic acid induced phosphorylation on additional sites, which could have a role in signalling pathways not yet identified.

Indexed as

3',5'-Cyclic-AMP PhosphodiesterasesAdipocytesAnimalsCyclic Nucleotide Phosphodiesterases, Type 3Enzyme ActivationEnzyme InhibitorsInsulinMarine ToxinsOkadaic AcidOxazolesPeptide MappingPhosphoprotein PhosphatasesPhosphorylationRats3',5'-Cyclic-AMP Phosphodiesterasescalyculin ACyclic Nucleotide Phosphodiesterases, Type 3Enzyme InhibitorsInsulinMarine ToxinsOkadaic AcidOxazolesPde3b protein, ratPhosphoprotein Phosphatases

Identifiers

PMID10417351
PMCPMC1220425
OpenAlexW2068085177

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.